Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting
Factor Bioscience to Deliver Six Digital Presentations at the American Society of Gene & Cell Therapy (ASGCT) 24th Annual Meeting -The presentations will reveal advances in mRNA, circleRNA, gene editing, cell reprogramming, and iPS cell-derived NK-cell technologies. - Factor's participation in this year's ASGCT Annual Meeting marks the company's ten-year anniversary and represents the most comprehensive presentation of the company's data to date. News provided by Share this article Share this article CAMBRIDGE, Mass., May 11, 2021 /PRNewswire/ -- Factor Bioscience Inc., a Cambridge-based bio...
Source: prnewswire.com